DERM Earnings

Quarterly EPS
$-0.12
Q3 2024
$0.07
Q4 2024
$-0.18
Q1 2025
$-0.16
Q2 2025
$-0.09
Q3 2025
$-0.05
Q4 2025
$-0.08
Q1 2026
$-0.01
Q2 2026
Latest Revenue17.8M
Latest Net Income-312000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.0117.8M-312000+18.9%+93.8%
Q1 2026-$0.0816.0M-2230000+21.5%+55.6%
Q4 2025-$0.0516.1M-1247000+27.3%-171.4%
Q3 2025-$0.0917.0M-2315000+16.4%+25.0%
Q2 2025-$0.1615.0M-3796000+1.0%+5.9%
Q1 2025-$0.1813.1M-4073000+0.8%+66.0%
Q4 2024$0.0712.6M1.5M-17.3%+163.6%
Q3 2024-$0.1214.6M-2390000-57.6%-113.2%
Q2 2024-$0.1714.9M-3361000
Q1 2024-$0.5313.0M-10442000
Q4 2023-$0.1115.3M-2143000
Q3 2023$0.9134.5M16.8M
Journey Medical (DERM) — Earnings